Apoptosis Induction, Disruption of Cytoskeleton Remodeling and EMT Inhibition as Major Mechanism(s) Underlying the Pleiotropic Action of Withania somnifera in Breast Cancer
- 6 April 2026
- journal article
- Published by Wiley in Cytoskeleton
Abstract
The role of actin and its binding proteins has been discovered in cytoskeleton remodeling as well as in Epithelial‐Mesenchymal Transition (EMT) of metastatic cells and apoptosis. Even minor changes in the biomolecular structure of actin and its ABPs (by binding of ligands) can lead to drastic changes in the cytoskeleton with far reaching effects per se. Agents targeting actin can, thus, be viewed as potential anti‐metastatic agents. The effect of Withania somnifera (L.) Dunal (WS) on the cytoskeleton has remained relatively unexplored. The present study highlights the interaction between 20 WS phytoconstituents and 10 selected cytoskeletal proteins in silico with a view to validate and analyze the perturbation in growth and differentiation of breast cancer cells in vitro. Pharmacokinetic analyses revealed that the majority of WS phytoconstituents exhibited no violations of Lipinski's rule‐of‐five parameters. Withanolides A, B, D, M and O displayed the greatest binding affinity particularly for coronin1A, vimentin, gelsolin, ezrin and F‐actin. MD simulations of 100 ns revealed maximum stable interaction(s) between Coronin‐Viscosalactone B (VISCB) and Vimentin‐Withanolide E (WITHE). The prepared methanolic extract of WS stem (WSME), characterized using LC–MS, revealed the presence of Withaferin A (WFA). Both WSME and WFA exhibited potent cytotoxicity against breast cancer MDA‐MB‐231 cells. WSME increased ROS levels, arrested the cell cycle in S and G2‐M phases, decreased the expression of mesenchymal markers, namely, vimentin, N‐cadherin and increased levels of the epithelial marker E‐cadherin in treated MDA‐MB‐231 cells. These findings suggest that VISCB, WITHE, and WFA have the potential to emerge as potential antimetastatic agents against breast cancer in the future.Keywords
This publication has 103 references indexed in Scilit:
- Withaferin A inhibits experimental epithelial-mesenchymal transition in MCF-10A cells and suppresses vimentin protein level in vivo in breast tumorsMolecular Carcinogenesis, 2013
- ERBB2 overexpression triggers transient high mechanoactivity of breast tumor cellsCytoskeleton, 2012
- Withaferin A inhibits breast cancer invasion and metastasis at sub‐cytotoxic doses by inducing vimentin disassembly and serine 56 phosphorylationInternational Journal of Cancer, 2011
- Multifunctional roles of gelsolin in health and diseasesMedicinal Research Reviews, 2010
- AutoDock Vina: Improving the speed and accuracy of docking with a new scoring function, efficient optimization, and multithreadingJournal of Computational Chemistry, 2009
- AutoDock4 and AutoDockTools4: Automated docking with selective receptor flexibilityJournal of Computational Chemistry, 2009
- Cytotoxic Withanolides from Physalis angulata L.Chemistry & Biodiversity, 2007
- GROMACS: Fast, flexible, and freeJournal of Computational Chemistry, 2005
- New Withanolides and Other Constituents from the Fruit of Withania somniferaArchiv der Pharmazie, 2002
- Effect of withaferin a on ehrlich ascites tumor cells — cytological observationsInternational Journal of Cancer, 1970